CF
HZNP

Centaurus Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Centaurus Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,327
Closed -$154K – 825
2023
Q3 		$154K Hold
1,327
– – 0.01% 635
2023
Q2 		$136K Sell
1,327
-113
-8% -$11.9K 0.01% 661
2023
Q1 		$157K Buy
1,440
+13
+0.9% +$1.44K 0.01% 730
2022
Q4 		$162K Buy
+1,427
New +$119K 0.02% 659
2022
Q3 		– Sell
-1,529
Closed -$122K – 911
2022
Q2 		$122K Sell
1,529
-520
-25% -$49.2K 0.01% 748
2022
Q1 		$216K Buy
2,049
+50
+3% +$4.87K 0.02% 647
2021
Q4 		$215K Sell
1,999
-5,601
-74% -$611K 0.02% 660
2021
Q3 		$833K Buy
7,600
+55
+0.7% +$5.71K 0.07% 307
2021
Q2 		$707K Sell
7,545
-92
-1% -$8.47K 0.06% 338
2021
Q1 		$703K Buy
7,637
+556
+8% +$46.9K 0.07% 299
2020
Q4 		$518K Buy
7,081
+5,399
+321% +$401K 0.05% 349
2020
Q3 		$131K Buy
+1,682
New +$116K 0.02% 550

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Centaurus Financial's HZNP Position: Q4 2023 in Review

Centaurus Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,327 shares — an estimated $154K sold.

Centaurus Financial first reported a position in HZNP in Q3 2020 and held it in 12 quarters. The position peaked at $833K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Centaurus Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Centaurus Financial sold 1,327 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $154K.
  • Centaurus Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 12 quarters.
  • Centaurus Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $833K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Centaurus Financial's 13F filing for Q4 2023, filed 26 Feb 2024.